Latest news with #DavidDardashti
Associated Press
25-06-2025
- Health
- Associated Press
Ibogaine by David Dardashti Announces Grand Opening of Second Ibogaine Clinic in Playa del Carmen, Mexico, Focusing on Non-Substance Related Disorders
Playa del Carmen, Mexico - June 24, 2025 - Ibogaine by David Dardashti, a globally recognized leader in ibogaine treatment, proudly announces the grand opening of its second state-of-the-art clinic in the serene coastal city of Playa del Carmen, Mexico. This significant expansion is a direct response to the escalating demand for comprehensive ibogaine-assisted therapies and marks a pivotal moment in the organization's commitment to advancing holistic wellness. The new facility will specifically cater to individuals seeking profound healing from non-substance related disorders, including trauma, depression, Parkinson's disease, and those requiring an executive reset for mental clarity and peak performance. The new Playa del Carmen clinic represents a significant evolution in therapeutic environments. Designed with meticulous attention to detail, it offers a distinct, tranquil, and deeply relaxed setting, carefully separated from the existing facility that primarily addresses substance use disorders. This intentional segregation ensures that each client receives highly specialized care tailored to their unique needs, fostering an atmosphere conducive to profound introspection and healing without external distractions. 'We are incredibly excited to open this new clinic, which embodies our vision for a more expansive and nuanced approach to ibogaine therapy,' said David Dardashti, founder of Ibogaine by David Dardashti. 'The overwhelming demand, particularly from individuals seeking solutions for complex conditions like trauma, depression, and neurological challenges such as Parkinson's, underscored the critical need for a dedicated space. This new center allows us to provide an even more focused, nurturing, and specialized environment, ensuring every individual's journey is supported with the highest degree of care and personalized attention.' Beyond its tranquil setting, the new clinic introduces several innovative programs designed to enhance the overall ibogaine experience and facilitate lasting change. A cornerstone of the new offering is an intensified focus on integration therapy, providing robust support for clients to process their experiences and incorporate new insights into their daily lives post-treatment. Complementing this, clients will have access to enriching local excursions, allowing them to connect with the vibrant culture and natural beauty of Playa del Carmen, fostering a sense of grounding and renewal. Daily yoga sessions will promote physical and mental well-being, while a groundbreaking introduction of project-based learning aims to engage clients in meaningful activities that stimulate cognitive function, foster creativity, and build self-efficacy, further enhancing the 'executive reset' component. The clinic's mission is to offer an extraordinary ibogaine experience, pushing the boundaries of therapeutic innovation. By combining the powerful properties of ibogaine with a holistic suite of supportive therapies and a dedicated focus on non-substance related challenges, Ibogaine by David Dardashti aims to set a new standard for transformative wellness. This expansion underscores the organization's unwavering dedication to providing accessible, cutting-edge treatments that empower individuals to achieve lasting health, clarity, and well-being. About Ibogaine by David Dardashti: Ibogaine by David Dardashti is a renowned leader in ibogaine treatment, committed to providing safe, effective, and compassionate care. With years of experience and a deep understanding of ibogaine's therapeutic potential, the organization strives to help individuals achieve profound healing and transformation from a range of conditions. Media Contact Company Name: Ibogaine By David Dardashti Contact Person: Cole Barressi Email: Send Email Country: United States Website: Press Release Distributed by To view the original version on ABNewswire visit: Ibogaine by David Dardashti Announces Grand Opening of Second Ibogaine Clinic in Playa del Carmen, Mexico, Focusing on Non-Substance Related Disorders
Globe and Mail
24-06-2025
- Health
- Globe and Mail
Ibogaine by David Dardashti Announces Grand Opening of Second Ibogaine Clinic in Playa del Carmen, Mexico, Focusing on Non-Substance Related Disorders
Playa del Carmen, Mexico - June 24, 2025 - Ibogaine by David Dardashti, a globally recognized leader in ibogaine treatment, proudly announces the grand opening of its second state-of-the-art clinic in the serene coastal city of Playa del Carmen, Mexico. This significant expansion is a direct response to the escalating demand for comprehensive ibogaine-assisted therapies and marks a pivotal moment in the organization's commitment to advancing holistic wellness. The new facility will specifically cater to individuals seeking profound healing from non-substance related disorders, including trauma, depression, Parkinson's disease, and those requiring an executive reset for mental clarity and peak performance. The new Playa del Carmen clinic represents a significant evolution in therapeutic environments. Designed with meticulous attention to detail, it offers a distinct, tranquil, and deeply relaxed setting, carefully separated from the existing facility that primarily addresses substance use disorders. This intentional segregation ensures that each client receives highly specialized care tailored to their unique needs, fostering an atmosphere conducive to profound introspection and healing without external distractions. "We are incredibly excited to open this new clinic, which embodies our vision for a more expansive and nuanced approach to ibogaine therapy," said David Dardashti, founder of Ibogaine by David Dardashti. "The overwhelming demand, particularly from individuals seeking solutions for complex conditions like trauma, depression, and neurological challenges such as Parkinson's, underscored the critical need for a dedicated space. This new center allows us to provide an even more focused, nurturing, and specialized environment, ensuring every individual's journey is supported with the highest degree of care and personalized attention." Beyond its tranquil setting, the new clinic introduces several innovative programs designed to enhance the overall ibogaine experience and facilitate lasting change. A cornerstone of the new offering is an intensified focus on integration therapy, providing robust support for clients to process their experiences and incorporate new insights into their daily lives post-treatment. Complementing this, clients will have access to enriching local excursions, allowing them to connect with the vibrant culture and natural beauty of Playa del Carmen, fostering a sense of grounding and renewal. Daily yoga sessions will promote physical and mental well-being, while a groundbreaking introduction of project-based learning aims to engage clients in meaningful activities that stimulate cognitive function, foster creativity, and build self-efficacy, further enhancing the "executive reset" component. The clinic's mission is to offer an extraordinary ibogaine experience, pushing the boundaries of therapeutic innovation. By combining the powerful properties of ibogaine with a holistic suite of supportive therapies and a dedicated focus on non-substance related challenges, Ibogaine by David Dardashti aims to set a new standard for transformative wellness. This expansion underscores the organization's unwavering dedication to providing accessible, cutting-edge treatments that empower individuals to achieve lasting health, clarity, and well-being. About Ibogaine by David Dardashti: Ibogaine by David Dardashti is a renowned leader in ibogaine treatment, committed to providing safe, effective, and compassionate care. With years of experience and a deep understanding of ibogaine's therapeutic potential, the organization strives to help individuals achieve profound healing and transformation from a range of conditions.
Associated Press
20-06-2025
- Business
- Associated Press
Ibogaine by David Dardashti Forges Strategic Partnership with Psychedelic University to Cultivate Next-Generation Leaders in Psychedelic Healthcare
MIAMI, FL - June 20, 2025 - Ibogaine by David Dardashti, a pioneering leader in ibogaine-assisted therapy and led by visionary David Dardashti, today announced a groundbreaking collaboration with a Psychedelic University. This strategic partnership aims to establish robust internship opportunities for students passionate about contributing to the rapidly evolving psychedelic field, with initial networking prospects to be explored at the highly anticipated Psychedelic Conference 2025. The initiative is further amplified by the recent opening of Ibogaine by David Dardashti's second state-of-the-art treatment facility, significantly expanding the scope for student involvement. This innovative alliance is designed to bridge the gap between academic learning and practical application, providing students with invaluable hands-on experience in a clinical setting dedicated to transformative healing. The expansion into a second facility dramatically increases Ibogaine by David Dardashti's capacity, creating a diverse array of potential roles for aspiring professionals. 'We are incredibly excited to partner with Psychedelic University to nurture the next generation of leaders in psychedelic medicine,' said David Dardashti, founder of Ibogaine by David Dardashti. 'The opening of our second clinic is not just about expanding our treatment capabilities; it's about building a robust ecosystem where ambitious students can gain real-world experience and help accelerate the growth and acceptance of ibogaine therapy. We believe this collaboration will foster innovation and ethical practices crucial for the future of this field.' The internship program will offer multifaceted opportunities for students from various disciplines. Beyond direct clinical exposure, students can expect to engage in critical areas such as: Meetings will be held in the months following a patient's treatment, creating a unique longitudinal learning environment where interns can observe the full spectrum of patient journeys and recovery. This comprehensive approach ensures that students gain a holistic understanding of patient care, from initial intake to long-term integration support. Representatives from both Ibogaine by David Dardashti and Psychedelic University will be actively engaging with students at the Psychedelic Conference 2025, providing a premier platform for aspiring interns to learn more about these opportunities and network with pioneers in the field. This direct interaction will allow students to present their aspirations and demonstrate their commitment to this burgeoning area of healthcare. The ultimate goal of Ibogaine by David Dardashti is to expand its new clinic with the support of ambitious, dedicated students who are eager to contribute to accelerating the growth and responsible application of ibogaine treatment. This partnership underscores a shared commitment to innovation, education, and the widespread, ethical integration of psychedelic therapies into mainstream healthcare. Media Contact Company Name: Ibogaine By David Dardashti Contact Person: Cole Barressi Email: Send Email Country: United States Website: Press Release Distributed by To view the original version on ABNewswire visit: Ibogaine by David Dardashti Forges Strategic Partnership with Psychedelic University to Cultivate Next-Generation Leaders in Psychedelic Healthcare
Globe and Mail
20-06-2025
- Health
- Globe and Mail
Ibogaine by David Dardashti Forges Strategic Partnership with Psychedelic University to Cultivate Next-Generation Leaders in Psychedelic Healthcare
MIAMI, FL - June 20, 2025 - Ibogaine by David Dardashti, a pioneering leader in ibogaine-assisted therapy and led by visionary David Dardashti, today announced a groundbreaking collaboration with a Psychedelic University. This strategic partnership aims to establish robust internship opportunities for students passionate about contributing to the rapidly evolving psychedelic field, with initial networking prospects to be explored at the highly anticipated Psychedelic Conference 2025. The initiative is further amplified by the recent opening of Ibogaine by David Dardashti's second state-of-the-art treatment facility, significantly expanding the scope for student involvement. This innovative alliance is designed to bridge the gap between academic learning and practical application, providing students with invaluable hands-on experience in a clinical setting dedicated to transformative healing. The expansion into a second facility dramatically increases Ibogaine by David Dardashti's capacity, creating a diverse array of potential roles for aspiring professionals. "We are incredibly excited to partner with Psychedelic University to nurture the next generation of leaders in psychedelic medicine," said David Dardashti, founder of Ibogaine by David Dardashti. "The opening of our second clinic is not just about expanding our treatment capabilities; it's about building a robust ecosystem where ambitious students can gain real-world experience and help accelerate the growth and acceptance of ibogaine therapy. We believe this collaboration will foster innovation and ethical practices crucial for the future of this field." The internship program will offer multifaceted opportunities for students from various disciplines. Beyond direct clinical exposure, students can expect to engage in critical areas such as: Therapy Options: Assisting in the development and delivery of integrative post-treatment care plans, including counseling and psychological support. Data Collection & Analysis: Contributing to the meticulous gathering and interpretation of patient outcomes, vital for advancing research and validating treatment efficacy. Biomedical Software Development: Participating in the creation and refinement of digital tools designed to enhance patient management, treatment protocols, and research analytics. Marketing Solutions: Developing strategic communication plans to educate the public, destigmatize ibogaine, and expand access to treatment. Meetings will be held in the months following a patient's treatment, creating a unique longitudinal learning environment where interns can observe the full spectrum of patient journeys and recovery. This comprehensive approach ensures that students gain a holistic understanding of patient care, from initial intake to long-term integration support. Representatives from both Ibogaine by David Dardashti and Psychedelic University will be actively engaging with students at the Psychedelic Conference 2025, providing a premier platform for aspiring interns to learn more about these opportunities and network with pioneers in the field. This direct interaction will allow students to present their aspirations and demonstrate their commitment to this burgeoning area of healthcare. The ultimate goal of Ibogaine by David Dardashti is to expand its new clinic with the support of ambitious, dedicated students who are eager to contribute to accelerating the growth and responsible application of ibogaine treatment. This partnership underscores a shared commitment to innovation, education, and the widespread, ethical integration of psychedelic therapies into mainstream healthcare.
Globe and Mail
20-06-2025
- Health
- Globe and Mail
Ibogaine by David Dardashti to Illuminate the Transformative Ibogaine Experience at Psychedelic Conference 2025
DENVER, CO - June 20, 2024 - Ibogaine by David Dardashti, a pioneer in holistic Ibogaine therapy, is proud to announce its prominent participation on Day 2 of the highly anticipated Psychedelic Conference 2025. David Dardashti and his team will offer individual descriptions of the unique Ibogaine experience, providing invaluable insights for each and every person at the conference seeking information regarding profound and lasting healing from addiction, trauma, and other mental health challenges. The core of the discussion will center on the therapeutic journey of Ibogaine. Patients describe the experience as a profound, introspective voyage through the past, present, and even potential future aspects of their lives. Unlike other therapies, Ibogaine often facilitates a unique perspective, allowing individuals to revisit significant life events and internalize them not from their own clouded emotional state, but from the detached, objective viewpoint of an outside observer. This remarkable shift in perspective enables deep understanding, reconciliation, and the ability to release long-held emotional burdens, fostering genuine personal growth and a renewed sense of purpose. Ibogaine by David Dardashti emphasizes highly individualized treatment protocols. The duration of an Ibogaine treatment varies, ranging from a focused 4-day experience to a comprehensive 21-day program, depending on the individual's specific needs, medical history, and the nature of their condition. Dosing is meticulously spread throughout the treatment period, starting with an initial transformative dose designed to interrupt cycles of dependence or deeply seated psychological patterns. This is often followed by carefully administered booster doses and, for longer programs, microdoses that support integration, neurogenesis, and sustained well-being in the weeks following the primary experience. This structured approach ensures both safety and maximal therapeutic benefit. "Ibogaine therapy, when administered with profound care and expertise, is not merely a detox; it is an awakening," says David Dardashti. "We guide individuals through a process that helps them confront their past, understand their present, and envision a healthier future. It's about empowering them to rewrite their narrative from a place of clarity and self-compassion, leading to truly sustainable transformation." Attendees of the Psychedelic Conference 2025 are invited to engage with Ibogaine by David Dardashti on Day 2 to gain a comprehensive understanding of this powerful plant medicine, its meticulous application, and the life-altering benefits it offers to those ready to embark on a journey of profound self-discovery and healing. About Ibogaine by David Dardashti: Ibogaine by David Dardashti is dedicated to providing safe, compassionate, and highly effective Ibogaine treatments. With a focus on individualized care, medical oversight, and comprehensive aftercare, the centers guide individuals towards sustainable recovery and improved mental well-being using the transformative properties of Ibogaine. About Psychedelic Conference 2025: The Psychedelic Conference 2025 is a leading international event bringing together researchers, practitioners, policymakers, and advocates to explore the latest advancements, therapeutic applications, and societal implications of psychedelic medicines.
